A ‘sci-fi’ cancer therapy fights brain tumors, study finds stat : The Seattle Times

"It's an incredible machine and I'm fine not having hair."___Online:Info on the device:http://www.novocure.com/http://www.youtube.com/watch?v=voVa7Pj2xUg&feature=youtu.beTreatment options for brain Cancer: http://1.usa.gov/ZqXBlzAmerican Cancer Society info: http://bit.ly/UJMhZG___Marilynn Marchione can be followed at http://twitter.com/MMarchioneAP The latest National Comprehensive Cancer Center guidelines include Optune as an appropriate treatment for brain tumors. THE NEW RESULTSNow they're in: Median survival was 21 months for those given Optune plus chemo versus 16 months for those on chemo alone. She has scans every two months to check for cancer and "they've all been good," she said. He led the company-sponsored study while previously at University Hospital Zurich in Switzerland, and gave results Sunday at an American Association for Cancer Research meeting in Washington.




___Online:Info on the device:http://www.novocure.com/http://www.youtube.com/watch?v=td5Ld3nURAI&feature=youtu.behttp://www.youtube.com/watch?v=5d13o1opr7s&feature=youtu.behttp://www.youtube.com/watch?v=voVa7Pj2xUg&feature=youtu.beTreatment options for brain Cancer: http://1.usa.gov/ZqXBlzAmerican Cancer Society info: http://bit.ly/UJMhZG The latest National Comprehensive Cancer Center guidelines include Optune as an appropriate treatment for brain tumors. advertisement | advertise on newsdayTHE NEW RESULTSNow they're in: Median survival was 21 months for those given Optune plus chemo versus 16 months for those on chemo alone. Doctors say many patients won't try the device because of the trouble involved or because they don't want a visible reminder of their cancer. He led the company-sponsored study while previously at University Hospital Zurich in Switzerland, and gave results Sunday at an American Association for Cancer Research meeting in Washington.


The latest National Comprehensive Cancer Center guidelines include Optune as an appropriate treatment for brain tumors. The new resultsNow they're in: Median survival was 21 months for those given Optune plus chemo versus 16 months for those on chemo alone. Doctors say many patients won't try the device because of the trouble involved or because they don't want a visible reminder of their cancer. He led the company-sponsored study while previously at University Hospital Zurich in Switzerland, and gave results Sunday at an American Association for Cancer Research meeting in Washington. It sounds like science fiction, but a cap-like device that makes electric fields to fight cancer improved survival for the first time in more than a decade for people with deadly brain tumors, final results of a large study suggest.


collected by :Lucy William

To follow all the new news about Health care